MedPath

Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease

Phase 2
Conditions
Eye Diseases
Registration Number
NCT00370734
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

In active phase of thyroid eye disease some patients have obvious upper lid retraction , and sometimes exposure keratopathy .To date there is not any standard treatment for this situation . We are going to compare the natural course of the upper lid retraction with injection of botulinum toxin A injection to upper lid percutaneously.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • all the patients wiht oper lid retraction in active phase of thyroid ophthalmopathy
Exclusion Criteria
  • patients in non active phase

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Babak Babsharif, MD

🇮🇷

Tehran, Iran, Islamic Republic of

Babak Babsharif, MD
🇮🇷Tehran, Iran, Islamic Republic of
Babak Babsharif, MD
Contact
+98 21 22585952
labbafi@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.